Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) will be hosting a conference call at 4:30 PM eastern time on 4th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.axonicsmodulation.com
Earnings Expectation
Axonics Modulation Technologies, Inc. is set to announce third quarter earning results on Wednesday 4th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, AXNX to report 3Q20 loss of $ 0.5 per share. For the full year, analysts anticipate top line of $ 94.55 million, while looking forward to loss of $ 1.9 per share bottom line.
Axonics Modulation Technologies, Inc., a medical technology company, focuses on the design, development, and commercialization of sacral neuromodulation solutions (SNM) solutions. The SNM therapy is primarily used to treat patients with overactive bladder, including urinary urgency incontinence and urinary urgency frequency, fecal incontinence, and urinary retention. Its proprietary r-SNM System delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of urinary and fecal dysfunction.
